• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于介导同种异体免疫细胞疗法的单行道识别方法。

A one-way street recognition approach to mediate allogeneic immune cell therapies.

机构信息

Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Division of Transplantation and Cellular Therapies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

出版信息

Cell Stem Cell. 2024 Sep 5;31(9):1239-1240. doi: 10.1016/j.stem.2024.07.005.

DOI:10.1016/j.stem.2024.07.005
PMID:39241752
Abstract

CD54 and CD58 are adhesion proteins that mediate efficient immune synapse formation. Hammer et al. now show that the abrogation of these molecules in T and NK cells prevents their immune rejection while maintaining their effector function. These findings should significantly help advance our efforts to generate "off-the-shelf" allogeneic products.

摘要

CD54 和 CD58 是黏附蛋白,可介导有效的免疫突触形成。Hammer 等人现在表明,在 T 和 NK 细胞中敲除这些分子可防止其免疫排斥,同时保持其效应功能。这些发现应该会极大地帮助我们推进“现成”同种异体产品的研发。

相似文献

1
A one-way street recognition approach to mediate allogeneic immune cell therapies.一种用于介导同种异体免疫细胞疗法的单行道识别方法。
Cell Stem Cell. 2024 Sep 5;31(9):1239-1240. doi: 10.1016/j.stem.2024.07.005.
2
CD58 Immunobiology at a Glance.CD58 免疫生物学速览。
Front Immunol. 2021 Jun 8;12:705260. doi: 10.3389/fimmu.2021.705260. eCollection 2021.
3
Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.遗传剔除黏附配体可减轻同种异体细胞免疫疗法的排斥反应。
Cell Stem Cell. 2024 Sep 5;31(9):1376-1386.e8. doi: 10.1016/j.stem.2024.06.011. Epub 2024 Jul 8.
4
Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.针对LFA-3和HER2/neu的两种不同的抗体依赖性细胞毒性机制可增强自然杀伤细胞对乳腺癌靶标的细胞毒性。
Exp Hematol. 1999 Oct;27(10):1533-41. doi: 10.1016/s0301-472x(99)00089-2.
5
CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.CD18/CD54(+CD102)、CD2/CD58途径非依赖性的淋巴因子激活的杀伤细胞(LAK细胞)对胶质母细胞瘤细胞系T98G和U373MG的杀伤作用
Oncol Res. 2000;12(1):17-24. doi: 10.3727/000000001108747408.
6
Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.利用细胞和基因组修饰技术来生成改良的“现货”CAR T 和 CAR NK 细胞。
Front Immunol. 2020 Aug 7;11:1965. doi: 10.3389/fimmu.2020.01965. eCollection 2020.
7
Study of the physical meaning of the binding parameters involved in effector-target conjugation using monoclonal antibodies against adhesion molecules and cholera toxin.使用抗粘附分子单克隆抗体和霍乱毒素研究效应物-靶标缀合中涉及的结合参数的物理意义。
Cell Immunol. 2002 Feb;215(2):141-50. doi: 10.1016/s0008-8749(02)00023-0.
8
The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.新型免疫治疗分子T11TS调节胶质瘤诱导的免疫突触关键成分的变化,有利于T细胞活化和胶质瘤消除。
J Neurooncol. 2014 Oct;120(1):19-31. doi: 10.1007/s11060-014-1528-9. Epub 2014 Jul 16.
9
Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.人黑色素瘤细胞中细胞黏附分子CD54/CD11a和CD58/CD2的差异表达及其在与细胞毒性细胞相互作用中的功能作用。
Cancer Res. 1993 Jul 15;53(14):3343-8.
10
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.自然杀伤细胞在多发性硬化症复发缓解患者自体造血干细胞移植后调节 Th17 细胞。
Front Immunol. 2018 May 7;9:834. doi: 10.3389/fimmu.2018.00834. eCollection 2018.

引用本文的文献

1
A potential prognostic marker for hematologic neoplasms: CD58.血液肿瘤的一种潜在预后标志物:CD58。
Front Oncol. 2025 Apr 29;15:1586842. doi: 10.3389/fonc.2025.1586842. eCollection 2025.